VSM MedTech Ltd. (VSM.TO) Buy, Sell or Hold

VSM MedTech Ltd. (VSM.TO)

0.00

-0.00 (0.00%)

0 watching

DON'T BUY

Likes this. Core business is selling broadcast equipment to cable and telcos. Have done a great job of creating shareholder value by selling off non-core assets such as wireless spectrum and real estate in Saskatchewan. Thinks they are kind of getting to the end of the line and he has sold his position.

Wealthica Track your Stocks in your Watch List

DON'T BUY

Recently entered into a financing agreement. Cash strapped. Existing shareholders tend to get totally diluted of their positions.

SELL

Ranks near the bottom. Earnings have been shaved by 23%. Recent financing was very dilutive.

DON'T BUY

Ranks in the bottom 1% of his database. Earnings estimates have been revised downwards 12% in the last 90 days.

DON'T BUY

It is interesting technology. The company is suffering. Give it a pass. He has owned in the past.

DON'T BUY

Has very good technology, but unfortunately it is still in the early stages of being rolled out to the medical community. In the bottom 15% of his database. Earnings estimates have been shaved by about 5% in the last 90 days and 20% in the last 60 days. Most recent quarter had a negative earnings surprise. Expected to lose $0.23 in ’06 and $0.15 in ’07.

PAST TOP PICK

(A Top Pick Nov 19/03. Down 83%.) Stock did very well for a whle, but the company was not able to make a viable business. Sold off a long time ago.

DON'T BUY

A tough one because the company is struggling with a management team that is being paid too much. Not doing well from a sales point of view and one of their competitors is starting to give away products as a bundling package.

Wealthica Track your Stocks in your Watch List

TRADE

The bane of his existence. Comes back to haunt him. Has not got this one right at all.

TRADE

Have had a lot of trouble. Lost their CEO. Have to do more research with management before investing. Have some interesting technology. Starting to look interesting.

BUY

Likes the company and their technology. Management team is improving operations, but they get paid way too much money. The question is; are they going to increase their sales base and ultimately sell the company or dwindle as a small cap. Under $1 there's not a whole lot of risk.

DON'T BUY

Not expected to earn any money. In the bottom 2% of the database. Year over year sales are down 43% and earnings down 71%.

DON'T BUY

CFO is gone and they have laid off the COO. Have sold zero units of their new technology. Running out of cash.

BUY ON WEAKNESS

Have been looking at it. Been beaten up more than it should be. Entering tax-loss selling season, so it could drop further. Still believes in the technology. New management could make a difference.

WAIT

Short term, it won't be good. Expect some tax loss selling in the last quarter. May take 3/4 years to get a big bang. Good product.

Showing 1 to 15 of 58 entries

VSM MedTech Ltd. (VSM.TO) Frequently Asked Questions

What is VSM MedTech Ltd. stock symbol?

VSM MedTech Ltd. is a OTC stock, trading under the symbol VSM.TO (previously VSM-T on Stockchase) on the undefined (undefined). It is usually referred to as or VSM.TO

Is VSM MedTech Ltd. a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on VSM.TO (previously VSM-T on Stockchase) on Stockchase. Read the latest expert commentary for VSM MedTech Ltd..

Is VSM MedTech Ltd. a good investment or a top pick?

VSM MedTech Ltd. was recommended as a Top Pick by Peter Hodson on 2004-09-24. Read the latest stock experts ratings for VSM MedTech Ltd..

Why is VSM MedTech Ltd. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for VSM MedTech Ltd..

Is VSM MedTech Ltd. worth watching?

VSM MedTech Ltd. is covered by Stockchase experts and is worth watching.

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

VSM MedTech Ltd. (VSM.TO)